Common use of Extension Payment Clause in Contracts

Extension Payment. Allarity and Eisai desire to extend the timeframe for ▇▇▇▇▇▇▇▇’ s Successful Completion of the first Phase 2 Clinical Trial of the Product beyond December 31, 2022. In consideration of this extended timeframe, and ▇▇▇▇▇▇▇▇ not achieving the minimum patient enrollment, by July 1, 2022, set out in the Second Amendment, ▇▇▇▇▇▇▇▇ agrees to pay a one-time payment to Eisai of One Million Two Hundred and Fifty Thousand U.S. Dollars ($1,250,000) (the “Extension Payment”) as follows: (i) Two hundred and fifty thousand dollars ($250,000) (which has already been paid); and (ii) One hundred and fifty thousand dollars ($150,000) on or before May 1, 2024; and (iii) Eight Hundred and Fifty Thousand Dollars ($850,000) upon completion of a ten-million-dollar capital raising campaign, expected to take place before the end of May 2024, but in no event later than September 1, 2024.

Appears in 1 contract

Sources: Exclusive License Agreement (Allarity Therapeutics, Inc.)

Extension Payment. Allarity and Eisai desire to extend the timeframe for ▇▇▇▇▇▇▇▇’ s ’s Successful Completion of the first Phase 2 Clinical Trial of the Product beyond December 31, 2022. In consideration of this extended timeframe, and ▇▇▇▇▇▇▇▇ Allarity not achieving the minimum patient enrollment, by July 1, 2022, set out in the Second Amendment, ▇▇▇▇▇▇▇▇ agrees to Allarity shall pay a one-time payment to Eisai of One Million Two One Hundred and Fifty Thousand U.S. Dollars ($1,250,0001,100,000.00) (the “Extension Payment”) as follows: (i) Two One hundred and fifty thousand dollars ($250,000100,000.00) (which has already been paid)received; and (ii) One hundred and fifty Fifty thousand dollars ($150,00050,000.00) within ten (10) days of execution of this Fourth Amendment; and (iii) One Hundred Thousand Dollars ($100,000.00) upon completion of a seven-million-dollar capital raising campaign expected to take place in June 2023, but notwithstanding the above at least on or before May March 1, 2024; and (iiiiv) Eight Hundred and Fifty Thousand Dollars ($850,000850,000.00) upon completion of a ten-million-dollar capital raising campaign, expected to take place on or before the end of May 2024, but in no event later than September March 1, 2024.

Appears in 1 contract

Sources: Exclusive License Agreement (Allarity Therapeutics, Inc.)